Core Points - Zepp Health Corporation will report its second quarter 2025 unaudited financial results on August 3, 2025 [1] - A conference call is scheduled for 9:30 p.m. ET on the same day, with access details provided for participants [1] - The company has shipped over 200 million units of its products and operates in more than 90 countries and regions [2] Company Overview - Zepp Health Corporation is a leader in smart wearables and health technology, focusing on optimizing health, fitness, and wellness journeys [2] - The company operates under consumer brands such as Amazfit, Zepp Clarity, and Zepp Aura, utilizing its proprietary Zepp Digital Management Platform [2] - Founded in 2013 as Huami Corp., the company rebranded to Zepp Health Corporation in February 2021 to emphasize its health focus [2]

Group 1 - Guolian Minsheng (01456) expects a net profit of RMB 1.129 billion for the first half of 2025, representing a year-on-year increase of approximately 1183% [1] - NIO-SW (09866) saw a rise of over 10% as its sub-brand, Lido, officially launched pre-sales for its new model L90, priced starting at RMB 279,900, which is competitive against similar models [1] - China CNR (01766) rose over 7% following a profit warning, with the rail transit equipment industry showing high demand and Q2 performance exceeding expectations [1] Group 2 - Coal stocks experienced a broad increase, with companies like China Qinfa (00866) and China Shenhua (01088) rising over 4%, driven by strong coal prices amid high temperatures [1] - Zijin Mining (02899) saw a rise of 1.5%, with expected net profit growth of about 54% year-on-year for the first half of the year, although short-term impacts from copper tariffs are anticipated [1] Group 3 - WanGuo Data-SW (09698) increased over 6% after its REIT completed offline inquiries with a subscription multiple of 166 times, indicating significant valuation potential [2] - Hengrui Medicine (01276) rose over 4%, reaching a new high, with expectations that its performance and business development will act as key catalysts [2] - China Shipbuilding Defense (00317) increased over 5% as the merger of two shipbuilding companies approaches completion, with Q2 performance exceeding expectations [2] Group 4 - Bitcoin-related stocks saw significant gains, with Bit Origin (BTOG.US) rising 51.72% and SharpLink Gaming (SBET.US) increasing 17.15%, driven by a surge in Bitcoin prices [3] - Gold stocks strengthened amid geopolitical tensions, with Gold ETF (GLD.US) rising 0.96% and Barrick Mining (B.US) increasing 0.71% [3] Group 5 - British Petroleum (BP.US) rose 3.55% as the company anticipates an increase in Q2 oil production and strong trading performance [7] - Huami Technology (ZEPP.US) surged over 69%, projecting a 30% revenue growth for Q2, marking its first growth in three years [7]

Core Viewpoint - Zepp Health's stock price has more than doubled in the past two weeks, with a forecast of 30% revenue growth in Q2, marking the first year-on-year increase in three years [1][6] Group 1: Company Transformation - Zepp Health is transitioning from being a contract manufacturer for Xiaomi to developing its own brand, Amazfit, which is expected to drive growth [3][5] - The company has seen a significant decline in revenue due to its previous reliance on Xiaomi, but is now experiencing a recovery as it focuses on its own brand [5][6] Group 2: Market Dynamics - The cases of Zepp and New Oxygen reflect a shift in investor perception, recognizing that not all Chinese companies should be viewed with the same skepticism [4] - Despite recent stock price increases, Zepp's price-to-sales ratio remains low at 0.46, indicating potential for further upside compared to global competitors [4][5] Group 3: Financial Performance - In Q1, Zepp reported a slight revenue decline of 3.6% to $38.5 million, but anticipates a 30% revenue growth in Q2 [6] - The company is still operating at a loss, with a net loss of $19.7 million in Q1, although it is optimistic about future growth and margin improvements [6][7] Group 4: Product Development - The anticipated revenue growth is attributed to the successful launch of two new products, Amazfit Active 2 and Bip 6, which have received positive market feedback [6] - The company is addressing supply chain bottlenecks and aims to resolve these issues by the end of June [6]

Market Capitalization Overview - The market capitalizations of various companies are listed, with TAL Education Group at 14.172 billion, Vipshop at 9.155 billion, and others showing significant values [2]. - Notable changes in stock prices include a decrease of 0.15 (-0.84%) for TAL Education and an increase of 0.79 (+1.53%) for Vipshop [2]. Company Performance - Companies like 58.com and Weibo show market capitalizations of 24.36 billion and 18.04 billion respectively, with stock price changes of -0.04 (-0.41%) and +0.32 (+3.24%) [2]. - New Oriental Education has a market cap of 5.22 billion, with a stock price change of -0.03 (-1.37%) [2]. Sector Trends - The data indicates a mixed performance across the sector, with some companies like Huya and Xpeng showing slight increases in their stock prices, while others like Cheetah Mobile and Baidu experience declines [3]. - The overall market sentiment appears to be fluctuating, reflecting varying investor confidence in different companies within the sector [3].

Financial Performance - Zepp Health's revenue for 1Q25 was $38.5 million[7], meeting the guidance range - The company shipped 0.5 million units in 1Q25[8] - Adjusted net loss attributable to Zepp was $18.1 million[8] Revenue Breakdown - In 1Q25, revenue from Xiaomi wearable products accounted for 38.6%[11] while Amazfit-branded wearable products accounted for 61.4%[11] of total revenue - Year-over-year, Xiaomi wearable products revenue decreased by 67.3%[14], while Amazfit-branded wearable products decreased by 32.7%[12] Gross Margin Analysis - The total gross profit in 1Q25 was $14.4 million[17] - The gross margin for Amazfit-branded products was 37.3%[19] in 1Q25 - The gross margin for total products was 37.3%[19] in 1Q25 Operating Expenses - Adjusted operating expenses for 1Q25 included General & Administrative (G&A), Sales & Marketing (S&M), and Research & Development (R&D)[30] - Adjusted operating expenses as a percentage of total revenue were 16.2% for G&A, 35.8% for S&M, and 29.8% for R&D[32] Liquidity and Outlook - Zepp Health's cash and cash equivalents stood at $103.8 million[42] - The company expects net revenues to be between $50 million and $55 million[47] for the second quarter of 2025

Financial Performance - Zepp Health's revenue for Q2 2024 was $40.6 million, meeting the guidance range[7] - The company's revenue for 1H 2024 was $80.6 million, also meeting the guidance range[16] - Adjusted net loss attributable to Zepp was $9.9 million in Q2 2024[12] and $22.4 million for 1H 2024[20] - Basic loss per ADS was $0.17 in Q2 2024 and $0.39 in 1H 2024[50] - Adjusted basic loss per ADS was $0.15 in Q2 2024 and $0.34 in 1H 2024[51] Gross Margin - The gross margin for self-branded products in Q2 2024 was 40.3%[30], while for Xiaomi products it was 4.8%[30] - The total gross margin in Q2 2024 was 22.0%[30] - The gross margin for self-branded products in 1H 2024 was 38.5%[35], while for Xiaomi products it was 10.6%[35] - The total gross margin in 1H 2024 was 18.9%[35] Shipments - Total units shipped in Q2 2024 were 1.3 million[9], compared to 3.8 million in Q2 2023[9] - Total units shipped in 1H 2024 were 2.5 million[17], compared to 7.3 million in 1H 2023[17] Business Outlook - The company expects net revenues to be between $45 million and $60 million for the third quarter of 2024[59]

Zepp Health Earnings Presentation Third Quarter 2024 Investor Relations 18 November 2024 Table of Contents 3Q24 Financial and Operating Results 01 06 3Q24 Revenue and Gross Margin Trend 07 Adjusted Operating Expenses 2 Empowering Health, Inspiring Joy 02 9M24 Financial and Operating Results 03 Revenue 04 3Q24 Gross Margin 05 Business Outlook 9M24 Gross Margin 08 Net Income/ Earnings Performance Liquidity Position 09 10 3Q24 Financial and Operating Results $42.5 Million Revenue • Meeting guidance range 0.7 M ...

Zepp Health Earnings Presentation Fourth Quarter and Full Year 2024 Investor Relations 26 March 2025 Table of Contents 01 06 4Q24 Revenue and Gross Margin Trend 07 Adjusted Operating Expenses 08 Net Income/ Earnings Performance Liquidity Position 09 10 2 Empowering Health, Inspiring Joy 4Q24 Financial and Operating Results 02 FY24 Financial and Operating Results 03 Revenue 04 4Q24 Gross Margin 05 Business Outlook FY24 Gross Margin 4Q24 Financial and Operating Results $59.5 Million Revenue • Meeting guidance ...

Financial Data and Key Metrics Changes - The company reported a 10% year-over-year growth in Amazfit revenue, marking the first growth after two years of transformation [6] - Gross margin for Q1 2025 was 37.3%, higher than both Q4 2024 and Q1 2024, despite a negative impact from tariffs [28][29] - Operating expenses for Q1 totaled $31.5 million, an increase from $29.3 million in Q4 2024 and $27.8 million in Q1 2024 [30] Business Line Data and Key Metrics Changes - Amazfit branded products achieved a 10.2% year-over-year growth, reflecting strong market reception for new models Active2 and BIP6 [27] - The initial sales momentum of Active2 and BIP6 surpassed previous versions, securing top positions in major markets [12][15] Market Data and Key Metrics Changes - The U.S. market accounts for approximately 15% of the company's revenue, with tariffs currently having minimal impact on operations [9] - In Italy, the company's market share for no SIM smartwatch units reached 23.3%, ranking second in the core wearable smartwatch market [13] Company Strategy and Development Direction - The company is focusing on diversifying its supply chain and optimizing cost management to mitigate risks from geopolitical complexities [6][26] - Plans to strengthen presence in entry-level markets and deepen collaboration with offline channel partners are in place [22] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about achieving year-over-year growth in overall sales for the first time since 2021, driven by product innovation and partnerships [22][56] - The company remains vigilant regarding macroeconomic challenges but expects operational efficiencies to offset tariff impacts [37] Other Important Information - The company successfully refinanced a significant portion of its short-term debt into long-term instruments, improving liquidity [35] - The anticipated tariff impact for 2025 is estimated to be around $2 million to $3 million, which is expected to be offset by operational efficiency gains [37] Q&A Session Summary Question: Impact of tariffs on U.S. exports produced in Vietnam - The company expects a full-year tariff impact of $2 million to $3 million, which will be offset by global operating efficiency gains [40][41] Question: Market pricing strategies - The company is monitoring competitors and will adjust pricing strategies on a case-by-case basis, but does not plan to be the first mover [47] Question: Operating expenses reduction timeline - A significant reduction in operating expenses is expected in Q2, as Q1 expenses were influenced by product launch events [48] Question: New product launches for the year - The company aims to refresh all major product lines throughout the year, with multiple new product launches planned [50][54]

Financial Data and Key Metrics Changes - The company reported a 10% year-over-year growth in Amazfit revenue, marking the first growth after two years of transformation [7] - Gross margin for Q1 2025 was 37.3%, higher than both Q4 2024 and Q1 2024, despite a negative impact from a 20% U.S. tariff on China-made products [28][29] - Adjusted operating loss for Q1 2025 was $17.2 million, compared to a loss of $13.1 million in the same period of 2024 [33] Business Line Data and Key Metrics Changes - Amazfit branded products achieved a 10.2% year-over-year growth, reflecting strong market reception of newly launched models Active2 and BIP6 [27] - Sales of Amazfit products increased by more than 10% compared to the same quarter last year, indicating a successful strategic shift [11] Market Data and Key Metrics Changes - The U.S. market accounts for about 15% of the company's revenue, with minimal impact from tariffs currently [10] - In Italy, the company's market share of non-SIM smartwatch units reached 23.3%, ranking second in the core wearable smartwatch market [14] Company Strategy and Development Direction - The company is focusing on diversifying its supply chain and optimizing cost management to mitigate risks associated with geopolitical complexities [8] - Plans to strengthen presence in entry-level markets and deepen collaboration with offline channel partners are in place [22] - The company aims to launch a significant number of new products in 2025 and 2026 to restore growth and profitability [38] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about achieving year-over-year growth in overall sales for the first time since 2021, driven by product innovation and partnerships [22] - The anticipated tariff impact for 2025 is estimated to be around $2 million to $3 million, which is expected to be offset by global operating efficiency gains [37] Other Important Information - The company successfully refinanced a significant portion of its short-term debt into long-term instruments, improving liquidity and balance sheet flexibility [35] - Cash balance as of March 31 was $104 million, a decrease from $110 million in Q4 2024, but managed through improved working capital [33] Q&A Session Summary Question: Impact of tariffs on U.S. exports produced in Vietnam - Management expects a full-year tariff impact of $2 million to $3 million, which will be offset by global operating efficiency gains [40][41] Question: Market pricing strategies - The company is not planning to be the first mover in raising prices and will monitor competitors before making adjustments [46][47] Question: Operating expenses reduction timeline - A significant reduction in operating expenses is expected in Q2, with Q1 being an outlier due to product launch events [48][49] Question: New product releases for the year - The company aims to refresh all major product lines throughout the year, with multiple new product launches planned [50][51]